FMC Corporation — Oct 29, 2025 release

Cash flow guidance has been lowered to a range of negative $200 million to $0 to reflect lower cash from operations. Full Year Outlook 2 (excludes H2 India) Fourth Quarter Outlook 2 (excludes India) Revenue $3.92 billion to $4.02 billion $1.12 billion to $1.22 billion Growth at midpoint vs. 2024 (7)% (4)% Adjusted EBITDA $830 million to $870 million $265 million to $305 million Growth at midpoint vs. 2024 (6)% (16)% Adjusted EPS^ $2.92 to $3.14 $1.14 to $1.36 Growth at midpoint vs. 2024 (13)% (30)% ^ EPS estimates assume 125.6 million diluted shares for full year and Q4. Note that percentages are calculated using whole numbers. Minor differences may exist due to rounding. Beginning with Q3 2025, India has been excluded from outlook. Variances are calculated versus 2024 results which include India. Page 6 / FMC Corporation Reports Third Quarter Results Cost Actions The company continues to evaluate its business to ensure alignment with strategic priorities and has concluded that a redesign of its manufacturing footprint is both necessary and timely. The company’s intent is to exit high-cost active ingredient and formulation plants and transition production to lower-cost sources. These actions are designed to establish a cost-competitive structure that enables FMC’s non-diamide core portfolio products to better compete with generics while capturing the full value of its innovative technology portfolio. The company is also implementing cost reduct